RNA-Targeting CRISPR-Cas systems and their applications
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–CRISPR-associated (Cas) systems have revolutionized modern molecular biology. Numerous types of these systems have been discovered to date. Many CRISPR–Cas systems have been used as a backbone for the development of potent research tools, with Cas9 being the most widespread. While most of the utilized systems are DNA-targeting, recently more and more attention is being gained by those that target RNA. Their ability to specifically recognize a given RNA sequence in an easily programmable way makes them ideal candidates for developing new research tools. In this review we summarize current knowledge on CRISPR–Cas systems which have been shown to target RNA molecules, that is type III (Csm/Cmr), type VI (Cas13), and type II (Cas9). We also present a list of available technologies based on these systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cas clusters described in PCC 9108 mainly belong to type III CRISPR -Cas systems, the most diverse and complex CRISPR, able to cleave RNA and DNA, and the only known that use three nuclease ac tivities (Burmistrz et al., 2020; Molina et al., 2020) (Table 1).”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Burmistrz et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Gootenberg, J. S., Abudayyeh, O. O., Kellner, M. J., Joung, J., Collins, J. J., & Zhang, F. (2018) · Science · doi:10.1126/science.aaq0179 · Cited by 2,638
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563 · cited 2×
“The 5′ fragment of tracrRNA binds to a repeat sequence, creating a duplex which is cleaved by RNase III [8].”
BackgroundC2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093
CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats
Grissa, I., Vergnaud, G., & Pourcel, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm360 · Cited by 1,875
Cox, D. B. T., Gootenberg, J. S., Abudayyeh, O. O., Franklin, B., Kellner, M. J., Joung, J., & Zhang, F. (2017) · Science · doi:10.1126/science.aaq0180 · Cited by 1,834
Identification of genes that are associated with DNA repeats in prokaryotes
Jansen, R., Embden, J. D. A. V., Gaastra, W., & Schouls, L. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02839.x · Cited by 1,802
RNA virus interference via CRISPR/Cas13a system in plants
Aman, R., Ali, Z., Butt, H., Mahas, A., Aljedaani, F., Khan, M. Z., Ding, S., & Mahfouz, M. (2018) · Genome Biology · doi:10.1186/s13059-017-1381-1 · Cited by 1,497
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Konermann, S., Lotfy, P., Brideau, N. J., Oki, J., Shokhirev, M. N., & Hsu, P. D. (2018) · Cell · doi:10.1016/j.cell.2018.02.033 · Cited by 1,164
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031
Diversity and evolution of class 2 CRISPR–Cas systems
Shmakov, S., Smargon, A., Scott, D., Cox, D., Pyzocha, N., Yan, W., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,029
CRISPR-Cas immunity in prokaryotes
Marraffini, L. A. (2015) · Nature · doi:10.1038/nature15386 · Cited by 829
Semenova, E., Jore, M. M., Datsenko, K. A., Semenova, A., Westra, E. R., Wanner, B., van der Oost, J., Brouns, S. J. J., & Severinov, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104144108 · Cited by 726
Unravelling the structural and mechanistic basis of CRISPR–Cas systems
van der Oost, J., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 714
Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli
Yosef, I., Goren, M. G., & Qimron, U. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks216 · Cited by 655
Programmable RNA recognition and cleavage by CRISPR/Cas9
O’Connell, M. R., Oakes, B. L., Sternberg, S. H., East-Seletsky, A., Kaplan, M., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13769 · Cited by 632
Smargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.023 · Cited by 575
Structural basis for CRISPR RNA-guided DNA recognition by Cascade
Jore, M. M., Lundgren, M., van Duijn, E., Bultema, J. B., Westra, E. R., Waghmare, S. P., Wiedenheft, B., Pul, Ü., Wurm, R., Wagner, R., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2019 · Cited by 562
The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a
Liu, L., Li, X., Ma, J., Li, Z., You, L., Wang, J., Wang, M., Zhang, X., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2017.06.050 · Cited by 538
CRISPR/Cas system: recent advances and future prospects for genome editing
Manghwar, H., Lindsey, K., Zhang, X., & Jin, S. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.09.006 · Cited by 529
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
Nelles, D. A., Fang, M. Y., O’Connell, M. R., Xu, J. L., Markmiller, S. J., Doudna, J. A., & Yeo, G. W. (2016) · Cell · doi:10.1016/j.cell.2016.02.054 · Cited by 527
A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G., & Siksnys, V. (2017) · Science · doi:10.1126/science.aao0100 · Cited by 521
Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
Niewoehner, O., Garcia-Doval, C., Rostøl, J. T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L. A., & Jinek, M. (2017) · Nature · doi:10.1038/nature23467 · Cited by 509
Yan, W. X., Chong, S., Zhang, H., Makarova, K. S., Koonin, E. V., Cheng, D. R., & Scott, D. A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.028 · Cited by 462
A CRISPR/Cas system mediates bacterial innate immune evasion and virulence
Sampson, T. R., Saroj, S. D., Llewellyn, A. C., Tzeng, Y.-L., & Weiss, D. S. (2013) · Nature · doi:10.1038/nature12048 · Cited by 443
Structures of the RNA-guided surveillance complex from a bacterial immune system
Wiedenheft, B., Lander, G. C., Zhou, K., Jore, M. M., Brouns, S. J. J., van der Oost, J., Doudna, J. A., & Nogales, E. (2011) · Nature · doi:10.1038/nature10402 · Cited by 397
Programmable Inhibition and Detection of RNA Viruses Using Cas13
Freije, C. A., Myhrvold, C., Boehm, C. K., Lin, A. E., Welch, N. L., Carter, A., Metsky, H. C., Luo, C. Y., Abudayyeh, O. O., Gootenberg, J. S., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.013 · Cited by 393
Self-targeting by CRISPR: gene regulation or autoimmunity?
Stern, A., Keren, L., Wurtzel, O., Amitai, G., & Sorek, R. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.008 · Cited by 384
Vercoe, R. B., Chang, J. T., Dy, R. L., Taylor, C., Gristwood, T., Clulow, J. S., Richter, C., Przybilski, R., Pitman, A. R., & Fineran, P. C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003454 · Cited by 341
RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes
East-Seletsky, A., O’Connell, M. R., Burstein, D., Knott, G. J., & Doudna, J. A. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.008 · Cited by 296
Hale, C. R., Majumdar, S., Elmore, J., Pfister, N., Compton, M., Olson, S., Resch, A. M., Glover, C. V. C., Graveley, B. R., Terns, R. M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.023 · Cited by 294
Structure and Mechanism of the CMR Complex for CRISPR-Mediated Antiviral Immunity
Zhang, J., Rouillon, C., Kerou, M., Reeks, J., Brugger, K., Graham, S., Reimann, J., Cannone, G., Liu, H., Albers, S.-V., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.013 · Cited by 292
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 282
Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d
Zhang, C., Konermann, S., Brideau, N. J., Lotfy, P., Wu, X., Novick, S. J., Strutzenberg, T., Griffin, P. R., Hsu, P. D., & Lyumkis, D. (2018) · Cell · doi:10.1016/j.cell.2018.09.001 · Cited by 276
Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A. O., Dickman, M. J., Horvath, P., & Siksnys, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.027 · Cited by 275
Classification and Nomenclature of CRISPR-Cas Systems: Where from Here?
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0033 · Cited by 270
Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č., & Siksnys, V. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.024 · Cited by 265
Anantharaman, V., Makarova, K. S., Burroughs, A. M., Koonin, E. V., & Aravind, L. (2013) · Biology Direct · doi:10.1186/1745-6150-8-15 · Cited by 262
Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9
Batra, R., Nelles, D. A., Pirie, E., Blue, S. M., Marina, R. J., Wang, H., Chaim, I. A., Thomas, J. D., Zhang, N., Nguyen, V., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.010 · Cited by 252
Establishing RNA virus resistance in plants by harnessing CRISPR immune system
Zhang, T., Zheng, Q., Yi, X., An, H., Zhao, Y., Ma, S., & Zhou, G. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12881 · Cited by 252
Cas9-mediated targeting of viral RNA in eukaryotic cells
Price, A. A., Sampson, T. R., Ratner, H. K., Grakoui, A., & Weiss, D. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422340112 · Cited by 250
Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system
Elmore, J. R., Sheppard, N. F., Ramia, N., Deighan, T., Li, H., Terns, R. M., & Terns, M. P. (2016) · Genes & Development · doi:10.1101/gad.272153.115 · Cited by 218
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity
Jiang, W., Samai, P., & Marraffini, L. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.053 · Cited by 202
Structure of the CRISPR Interference Complex CSM Reveals Key Similarities with Cascade
Rouillon, C., Zhou, M., Zhang, J., Politis, A., Beilsten-Edmands, V., Cannone, G., Graham, S., Robinson, C. V., Spagnolo, L., & White, M. F. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.020 · Cited by 188
RNA-dependent RNA targeting by CRISPR-Cas9
Strutt, S. C., Torrez, R. M., Kaya, E., Negrete, O. A., & Doudna, J. A. (2018) · eLife · doi:10.7554/elife.32724 · Cited by 186
RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex
Estrella, M. A., Kuo, F.-T., & Bailey, S. (2016) · Genes & Development · doi:10.1101/gad.273722.115 · Cited by 178
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S. A., Kostyusheva, A. P., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 139
Crystal Structure of the CRISPR-Cas RNA Silencing Cmr Complex Bound to a Target Analog
Osawa, T., Inanaga, H., Sato, C., & Numata, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.018 · Cited by 138
CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9
Dugar, G., Leenay, R. T., Eisenbart, S. K., Bischler, T., Aul, B. U., Beisel, C. L., & Sharma, C. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.032 · Cited by 135
Makarova, K. S., Anantharaman, V., Aravind, L., & Koonin, E. V. (2012) · Biology Direct · doi:10.1186/1745-6150-7-40 · Cited by 133
Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6
Niewoehner, O., & Jinek, M. (2016) · RNA · doi:10.1261/rna.054098.115 · Cited by 131
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Spilman, M., Cocozaki, A., Hale, C., Shao, Y., Ramia, N., Terns, R., Terns, M., Li, H., & Stagg, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.008 · Cited by 130
Structural Model of a CRISPR RNA-Silencing Complex Reveals the RNA-Target Cleavage Activity in Cmr4
Benda, C., Ebert, J., Scheltema, R. A., Schiller, H. B., Baumgärtner, M., Bonneau, F., Mann, M., & Conti, E. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.002 · Cited by 130
Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning
Taylor, D. W., Zhu, Y., Staals, R. H. J., Kornfeld, J. E., Shinkai, A., van der Oost, J., Nogales, E., & Doudna, J. A. (2015) · Science · doi:10.1126/science.aaa4535 · Cited by 129
Advances in CRISPR-Cas systems for RNA targeting, tracking and editing
Wang, F., Wang, L., Zou, X., Duan, S., Li, Z., Deng, Z., Luo, J., Lee, S. Y., & Chen, S. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.016 · Cited by 128
CRISPR interference: a structural perspective
Reeks, J., Naismith, J. H., & White, M. F. (2013) · Biochemical Journal · doi:10.1042/bj20130316 · Cited by 127
Targeted m6A Reader Proteins To Study Epitranscriptomic Regulation of Single RNAs
Rauch, S., He, C., & Dickinson, B. C. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05012 · Cited by 122
Hatoum-Aslan, A., Samai, P., Maniv, I., Jiang, W., & Marraffini, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499244 · Cited by 116
Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex
Hale, C. R., Cocozaki, A., Li, H., Terns, R. M., & Terns, M. P. (2014) · Genes & Development · doi:10.1101/gad.250712.114 · Cited by 111
CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus
Zebec, Z., Manica, A., Zhang, J., White, M. F., & Schleper, C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku161 · Cited by 101
Rousseau, B. A., Hou, Z., Gramelspacher, M. J., & Zhang, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.025 · Cited by 85
Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells
Banan, M. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.11.010 · Cited by 85
The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease
Sheppard, N. F., Glover, C. V. C., Terns, R. M., & Terns, M. P. (2016) · RNA · doi:10.1261/rna.039842.113 · Cited by 76
CRISPR/Cas system: An emerging technology in stem cell research
Valenti, M. T., Serena, M., Carbonare, L. D., & Zipeto, D. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.937 · Cited by 62
Impact of Different Target Sequences on Type III CRISPR-Cas Immunity
Maniv, I., Jiang, W., Bikard, D., & Marraffini, L. A. (2016) · Journal of Bacteriology · doi:10.1128/jb.00897-15 · Cited by 60
Goldberg, G. W., McMillan, E. A., Varble, A., Modell, J. W., Samai, P., Jiang, W., & Marraffini, L. A. (2017) · Nature Communications · doi:10.1038/s41467-017-02557-2 · Cited by 44
CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing
Manzoor, K. N., & Khan, A. A. (2019) · Journal of Basic Microbiology · doi:10.1002/jobm.201900420 · Cited by 43
Programmable type III-A CRISPR-Cas DNA targeting modules
Ichikawa, H. T., Cooper, J. C., Lo, L. F., Potter, J., Terns, R. M., & Terns, M. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176221 · Cited by 36
Shooting the messenger: RNA-targetting CRISPR-Cas systems
Zhu, Y., Klompe, S. E., Vlot, M., John van der, O. O. S. T., & Staals, R. H. J. (2018) · Bioscience Reports · doi:10.1042/bsr20170788 · Cited by 35
CRISPR-Cas Systems in Prokaryotes
Burmistrz, M., & Pyrć, K. (2015) · Polish Journal of Microbiology · doi:10.5604/01.3001.0009.2114 · Cited by 26
Self-citationKhosravi, S., Ishii, T., Dreißig, S., & Houben, A. (2019) · Chromosome Research · doi:10.1007/s10577-019-09622-0 · Cited by 20
Nickel, L., Ulbricht, A., Alkhnbashi, O. S., Förstner, K. U., Cassidy, L., Weidenbach, K., Backofen, R., & Schmitz, R. A. (2018) · RNA Biology · doi:10.1080/15476286.2018.1514234 · Cited by 16
Burmistrz, M., Martínez, J. I. R., Krochmal, D., Staniec, D., & Pyrć, K. (2017) · Journal of Bacteriology · doi:10.1128/jb.00275-17 · Cited by 9
Self-citationDead Cas Systems: Types, Principles, and Applications
Brezgin, S. A., Kostyusheva, A. P., Kostyushev, D. S., & Chulanov, V. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.14 · Cited by 5
Cited by
CRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,049
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 476
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
Atzrodt, C. L., Maknojia, I., McCarthy, R. D. P., Oldfield, T. M., Po, J., Ta, K. T. L., Stepp, H. E., & Clements, T. P. (2020) · The FEBS Journal · doi:10.1111/febs.15375 · Cited by 341
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., Barba-Ostria, C., & Guamán, L. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00649 · Cited by 207
Gene therapy for ALS: A review
Amado, D. A., & Davidson, B. L. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.008 · Cited by 184
Metadata
- Authors
- Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A.
- Affiliations
- Department of Molecular Microbiology, Biological and Chemical Research Centre, Faculty of Biology, University of Warsaw, 02-089 Warsaw, Poland
- University of Warsaw (PL)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-07
- Volume
- 21
- Issue
- 3
- Pages
- 1122
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7036953
- OpenAlex
- W3004935084
- Cited by
- 125
- References
- 81
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 8
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Center of Science, Poland (2016/21/B/NZ6/00963)
- Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw (intramural grant DSM no. 501-D114-01-1140400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, Cas13, type III CRISPR-Cas, RNA interference, RNA cleavage, genome editing tools
- MeSH terms
- Gene Editing, Animals, Humans, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.